|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase显示文摘 | Uyttenhove C Pilotte L Theate I | 2003 | Nat Med2003，9，10： | 1 |
| 2 | Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3 - dioxygenase 显示文摘 | Uyttenhove C Pilotte L Theate I | 2003 | Nat Med2003，9，10： | 1 |
| 3 | Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleam-ine 2,3-dioxygenase 显示文摘 | Uyttenhove C Pilotte L Theate I | 2003 | Nat Med2003，9，10： | 1 |
| 4 | Evidence for a tumoral im- mune resistance mechanism based on tryptophan degradalion by in- doleamine 2,3-dioxygenase显示文摘 | Uyttenhove C Pilotte L Theate I | 2003 | Nat Med2003，9，10： | 1 |
| 5 | Identification of dis- tinct gene expression profiles in the synovium of patients with sys- temic lupus erythematosus 显示文摘 | Nzeusseu Toukap A Galant C Theate I | 2007 | Arthritis Rheum2007，56，5： | 1 |
| 6 | Evidence for a tumoral im-mune resistance mechanism based on tryptophan degradation byindoleamine 2,3 - dioxygenase显示文摘 | Uyttenhove C Pilotte L Theate I | 2003 | Nat Med2003，9，10： | 1 |
| 7 | Hiv-associated multi- centricCastleman disease : a report of 4 cases and review of the lit erature显示文摘 | Jonckheere S Vandercam B Theate I | 2011 | Acta Clin Belg2011，66，： | 1 |
| 8 | Evidence for a tumoral immune resistance mechanism based tryptophan degradation by indoleamine 2,3-dioxygenase 显示文摘 | Uyttenhove C Pilotte L Theate I el al | 2003 | Nat Med2003，9，10： | 1 |
| 9 | Evidence for a tumoral immune resistance mechanism based on tryptophan deg- radation by indoleamine 2,3-dioxygenase显示文摘 | UYTTENHOVE C PILOTTE L THEATE I | 2003 | Nat Med2003，9，10： | 1 |
| 10 | Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase显示文摘 | Uyttenhove C Pilotte L Theate I | 2003 | Nature Medicine2003，9，10： | 1 |
| 11 | Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase显示文摘 | Uyttenhove C Pilotte L Theate I | 2003 | Nat Med2003，9，10： | 1 |
| 12 | Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase显示文摘 | Uyttenhove C Pilotte L Theate I | 2003 | Nat Med2003，9，10： | 1 |
| 13 | Distribution of Coliforms in the Seine River and Estuary (France) Studied by Rapid Enzymatic Methods and Plate Counts显示文摘 | GEORGE I PETIT M THEATE C | | 0，，06： | 1 |
| 14 | Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase显示文摘 | Pilotte L Theate I | 2003 | Nat Med2003，9，10： | 1 |
| 15 | Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase显示文摘 | Uyttenhove C Pilotte L Theate I | 2003 | Nat Med2003，9，10： | 1 |
| 16 | Evidence for a tumoral im2 mune resistancemechanism based on tryp tophan degradation by indoleamine 2, 3-dioxygenase显示文摘 | Uyttenhove C Pilotte L Theate I | 2003 | Nat Med2003，9，10： | 1 |
| 17 | Evidence for a tumonal immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase显示文摘 | Uyttenhove C Pilotte L Theate I | 2003 | Nat Med2003，9，10： | 1 |
| 18 | Evidence for a tumoral im- mune resistance mechanism based on tryptophan degradation by in- doleamine 2,3-dioxygenase 显示文摘 | Uyttenhove C Pilotte L Theate I | 2003 | Nat Med2003，9，10： | 1 |
| 19 | Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase显示文摘 | Uyttenhove C Pilotte L Theate I | 2003 | Nat Med2003，9，10： | 1 |
| 20 | Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase显示文摘 | Uyttenhove C Pilotte L Theate I | 2003 | Nat Med2003，9，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员